MicroRNAs in cardiovascular diseases: Biology and potential clinical applications

Journal of Cardiovascular Translational Research

Volumn 3, Issue 3, 2010, Pages 256-270

  Kartha, Reena V ^a   Subramanian, Subbaya ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cardiovascular diseases; Diagnostics; Heart; MicroRNA; Therapeutics

Indexed keywords

ADENOVIRUS VECTOR; ANTISENSE OLIGONUCLEOTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CONNECTIVE TISSUE GROWTH FACTOR; DICER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR; GELATINASE A; HEAT SHOCK PROTEIN 20; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MYOCARDIN; MYOCYTE ENHANCER FACTOR 2; MYOD PROTEIN; MYOSIN HEAVY CHAIN ALPHA; MYOSTATIN; OLIGONUCLEOTIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; SERUM RESPONSE FACTOR; SOMATOMEDIN C; TANSHINONE IIA; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NKX2.5; UNINDEXED DRUG; VASCULOTROPIN; GENETIC MARKER;

ANGIOGENESIS; ANTIARRHYTHMIC ACTIVITY; CARDIOVASCULAR DISEASE; DIAGNOSTIC VALUE; DISEASE MARKER; DRUG TARGETING; GENE CONTROL; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; HEART ARRHYTHMIA; HEART DEVELOPMENT; HEART FAILURE; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; TISSUE REGENERATION; TRANSLUMINAL CORONARY ANGIOPLASTY; VIRAL GENE THERAPY; ANIMAL; CARDIOVASCULAR DISEASES; GENE THERAPY; GENETIC MARKER; GENETIC SCREENING; GENETICS; HEART MUSCLE; METABOLISM; PREDICTIVE VALUE; REGENERATION; TREATMENT OUTCOME;

ANIMALS; CARDIOVASCULAR DISEASES; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC MARKERS; GENETIC TESTING; HUMANS; MICRORNAS; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; REGENERATION; TREATMENT OUTCOME; GENETIC THERAPY;

EID: 77955661276     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-010-9172-z     Document Type: Review

References (138)

1. Abbas, N. A., John, R. I., Webb, M. C., Kempson, M. E., Potter, A. N., Price, C. P., et al. (2005). Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clinical Chemistry, 51, 2059-2066.
2. Ai, J., Zhang, R., Li, Y., Pu, J., Lu, Y., Jiao, J., et al. (2010). Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochemical and Biophysical Research Communications, 391, 73-77.
3. Altuvia, Y., Landgraf, P., Lithwick, G., Elefant, N., Pfeffer, S., Aravin, A., et al. (2005). Clustering and conservation patterns of human microRNAs. Nucleic Acids Research, 33, 2697-2706.
4. Asangani, I. A., Rasheed, S. A., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., et al. (2008). MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27, 2128-2136.
5. Barringhaus, K. G., & Zamore, P. D. (2009). MicroRNAs: Regulating a change of heart. Circulation, 119, 2217-2224.
6. Bartel, D. P. (2009). MicroRNAs: Target recognition and regulatory functions. Cell, 136, 215-233.
7. Beltrami, A. P., Urbanek, K., Kajstura, J., Yan, S. M., Finato, N., Bussani, R., et al. (2001). Evidence that human cardiac myocytes divide after myocardial infarction. New England Journal of Medicine, 344, 1750-1757.
8. Bernstein, E., Kim, S. Y., Carmell, M. A., Murchison, E. P., Alcorn, H., Li, M. Z., et al. (2003). Dicer is essential for mouse development. Nature Genetics, 35, 215-217.
9. Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., et al. (2009). MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science, 324, 1710-1713.
10. Borchert, G. M., Lanier, W., & Davidson, B. L. (2006). RNA polymerase III transcribes humanmicroRNAs. Nature Structural & Molecular Biology, 13, 1097-1101.
11. Calin, G. A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S. E., et al. (2005). A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. New England Journal of Medicine, 353, 1793-1801.
12. Callis, T. E., Pandya, K., Seok, H. Y., Tang, R. H., Tatsuguchi, M., Huang, Z. P., et al. (2009).MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. Journal of Clinical Investigation, 119, 2772-2786.
13. Callis, T. E., & Wang, D. Z. (2008). Taking microRNAs to heart. Trends in Molecular Medicine, 14, 254-260.
14. Care, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., et al. (2007). MicroRNA-133 controls cardiac hypertrophy. Nature Medicine, 13, 613-618.
15. Chen, J. F., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., et al. (2006). The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nature Genetics, 38, 228-233.
16. Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., et al. (2008). Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 18, 997-1006.
17. Cheng, Y., Ji, R., Yue, J., Yang, J., Liu, X., Chen, H., et al. (2007). MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play a role in cardiac hypertrophy? American Journal of Pathology, 170, 1831-1840.
18. Cheng, Y., Liu, X., Yang, J., Lin, Y., Xu, D. Z., Lu, Q., et al. (2009). MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circulation Research, 105, 158-166.
19. Chim, S. S., Shing, T. K., Hung, E. C., Leung, T. Y., Lau, T. K., Chiu, R. W., et al. (2008). Detection and characterization of placental microRNAs in maternal plasma. Clinical Chemistry, 54, 482-490.
20. Clop, A., Marcq, F., Takeda, H., Pirottin, D., Tordoir, X., Bibe, B., et al. (2006). A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nature Genetics, 38, 813-818.
21. Cordes, K. R., Sheehy, N. T., White, M. P., Berry, E. C., Morton, S. U., Muth, A. N., et al. (2009). miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature, 460, 705-710.
22. Cordes, K. R., & Srivastava, D. (2009). MicroRNA regulation of cardiovascular development. Circulation Research, 104, 724-732.
23. Cortez, M. A., & Calin, G. A. (2009). MicroRNA identification in plasma and serum: A new tool to diagnose and monitor diseases. Expert Opinion on Biol Ther, 9, 703-711.
24. Currie, R. W., Tanguay, R. M., & Kingma, J. G., (1993). Heat-shock response and limitation of tissue necrosis during occlusion/reperfusion in rabbit hearts. Circulation, 87, 963-971.
25. da Costa Martins, P. A., Bourajjaj, M., Gladka, M., Kortland, M., van Oort, R. J., Pinto, Y. M., et al. (2008). Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation, 118, 1567-1576.
26. Divakaran, V., & Mann, D. L. (2008). The emerging role of microRNAs in cardiac remodeling and heart failure. Circulation Research, 103, 1072-1083.
27. Dong, S., Cheng, Y., Yang, J., Li, J., Liu, X., Wang, X., et al. (2009). MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. Journal of Biological Chemistry, 284, 29514-29525.
28. Duisters, R. F., Tijsen, A. J., Schroen, B., Leenders, J. J., Lentink, V., van der Made, I., et al. (2009). miR-133 and miR-30 regulate connective tissue growth factor: Implications for a role of microRNAs in myocardial matrix remodeling. Circ Res, 104, 170-178. 176p following 178.
29. Ebert, M. S., Neilson, J. R., & Sharp, P. A. (2007). MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells. Nat Methods, 4, 721-726.
30. Elmen, J., Lindow, M., Schutz, S., Lawrence, M., Petri, A., Obad, S., et al. (2008). LNA-mediated microRNA silencing in non-human primates. Nature, 452, 896-899.
31. Elmen, J., Lindow, M., Silahtaroglu, A., Bak, M., Christensen, M., Lind-Thomsen, A., et al. (2008). Antagonism of microRNA- 122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Research, 36, 1153-1162.
32. Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., et al. (2006). miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab, 3, 87-98.
33. Eulalio, A., Huntzinger, E., & Izaurralde, E. (2008). Getting to the root of miRNA-mediated gene silencing. Cell, 132, 9-14.
34. Fasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., et al. (2008). MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. Journal of Biological Chemistry, 283, 15878-15883.
35. Fish, J. E., Santoro, M.M., Morton, S. U., Yu, S., Yeh, R. F., Wythe, J. D., et al. (2008). miR-126 regulates angiogenic signaling and vascular integrity. Developments in Cell, 15, 272-284.
36. Frey, N., & Olson, E. N. (2003). Cardiac hypertrophy: The good, the bad, and the ugly. Annual Review of Physiology, 65, 45-79.
37. Friedman, R. C., Farh, K. K., Burge, C. B., & Bartel, D. P. (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Research, 19, 92-105.
38. Gilad, S., Meiri, E., Yogev, Y., Benjamin, S., Lebanony, D., Yerushalmi, N., et al. (2008). Serum microRNAs are promising novel biomarkers. PLoS ONE, 3, e3148.
39. Griffiths-Jones, S., Saini, H. K., van Dongen, S., & Enright, A. J. (2008). miRBase: Tools for microRNA genomics. Nucleic Acids Research, 36, D154-D158.
40. Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., et al. (2006). Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature, 441, 537-541.
41. Hoffman, J. I. (1995). Incidence of congenital heart disease: II. Prenatal incidence. Pediatric Cardiology, 16, 155-165.
42. Horie, T., Ono, K., Nishi, H., Iwanaga, Y., Nagao, K., Kinoshita, M., et al. (2009).MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes. Biochemical and Biophysical Research Communications, 389, 315-320.
43. Hunter, J. J., & Chien, K. R. (1999). Signaling pathways for cardiac hypertrophy and failure. New England Journal of Medicine, 341, 1276-1283.
44. Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., et al. (2008). Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE, 3, e3694.
45. Hutter, M. M., Sievers, R. E., Barbosa, V., & Wolfe, C. L. (1994). Heat-shock protein induction in rat hearts. A direct correlation between the amount of heat-shock protein induced and the degree of myocardial protection. Circulation, 89, 355-360.
46. Ikeda, S., Kong, S. W., Lu, J., Bisping, E., Zhang, H., Allen, P. D., et al. (2007). Altered microRNA expression in human heart disease. Physiological Genomics, 31, 367-373.
47. Ivey, K. N., Muth, A., Arnold, J., King, F.W., Yeh, R. F., Fish, J. E., et al. (2008). MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell, 2, 219-229.
48. Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., et al. (2006). Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing. RNA, 12, 1197-1205.
49. Ji, R., Cheng, Y., Yue, J., Yang, J., Liu, X., Chen, H., et al. (2007). MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circulation Research, 100, 1579-1588.
50. Ji, X., Takahashi, R., Hiura, Y., Hirokawa, G., Fukushima, Y., & Iwai, N. (2009). Plasma miR-208 as a biomarker of myocardial injury. Clinical Chemistry, 55, 1944-1949.
51. Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., et al. (2005). RAS is regulated by the let-7 microRNA family. Cell, 120, 635-647.
52. Kajstura, J., Urbanek, K., Rota, M., Bearzi, C., Hosoda, T., Bolli, R., et al. (2008). Cardiac stem cells and myocardial disease. Journal of Molecular and Cellular Cardiology, 45, 505-513.
53. Kim, H. W., Haider, H. K., Jiang, S., & Ashraf, M. (2009). Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8 associated protein 2. Journal of Biological Chemistry, 284, 33161-33168.
54. Kloosterman, W. P., Wienholds, E., Ketting, R. F., & Plasterk, R. H. (2004). Substrate requirements for let-7 function in the developing zebrafish embryo. Nucleic Acids Research, 32, 6284- 6291.
55. Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., et al. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Medicine, 7, 430-436.
56. Krutzfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., et al. (2005). Silencing of microRNAs in vivo with 'antagomirs'. Nature, 438, 685-689.
57. Kuehbacher, A., Urbich, C., & Dimmeler, S. (2008). Targeting microRNA expression to regulate angiogenesis. Trends in Pharmacological Sciences, 29, 12-15.
58. Kuehbacher, A., Urbich, C., Zeiher, A. M., & Dimmeler, S. (2007). Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circulation Research, 101, 59-68.
59. Kwon, C., Han, Z., Olson, E. N., & Srivastava, D. (2005). MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. Proceedings of the National Academy of Sciences of the United States of America, 102, 18986-18991.
60. Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., & Tuschl, T. (2002). Identification of tissue-specific micro- RNAs from mouse. Current Biology, 12, 735-739.
61. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell, 129, 1401-1414.
62. Laterza, O. F., Lim, L., Garrett-Engele, P. W., Vlasakova, K., Muniappa, N., Tanaka, W. K., et al. (2009). Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clinical Chemistry, 55, 1977-1983.
63. Latronico, M. V., Catalucci, D., & Condorelli, G. (2007). Emerging role of microRNAs in cardiovascular biology. Circulation Research, 101, 1225-1236.
64. Latronico, M. V., & Condorelli, G. (2009). MicroRNAs and cardiac pathology. Nature Reviews Cardiol, 6, 419-429.
65. Lee, I., Ajay, S. S., Yook, J. I., Kim, H. S., Hong, S. H., Kim, N. H., et al. (2009). New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites. Genome Res, 19, 1175-1183.
66. Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-854.
67. Lee, Y., Kim, M., Han, J., Yeom, K. H., Lee, S., Baek, S. H., et al. (2004). MicroRNA genes are transcribed by RNA polymerase II. EMBO Journal, 23, 4051-4060.
68. Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20.
69. Liu, J., Valencia-Sanchez, M. A., Hannon, G. J., & Parker, R. (2005). MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nature Cell Biology, 7, 719-723.
70. Liu, N., Williams, A. H., Kim, Y., McAnally, J., Bezprozvannaya, S., Sutherland, L. B., et al. (2007). An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proceedings of the National Academy of Sciences of the United States of America, 104, 20844-20849.
71. Liu, X., Cheng, Y., Zhang, S., Lin, Y., Yang, J., & Zhang, C. (2009). A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circulation Research, 104, 476-487.
72. Loya, C. M., Lu, C. S., Van Vactor, D., & Fulga, T. A. (2009). Transgenic microRNA inhibition with spatiotemporal specificity in intact organisms. Nat Methods, 6, 897-903.
73. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., et al. (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
74. Lu, Y., Zhang, Y., Shan, H., Pan, Z., Li, X., Li, B., et al. (2009). MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: A new mechanism for ischaemic cardioprotection. Cardiovascular Research, 84, 434-441.
75. Luo, X., Lin, H., Pan, Z., Xiao, J., Zhang, Y., Lu, Y., et al. (2008). Down-regulation of miR-1/miR-133 contributes to reexpression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. Journal of Biological Chemistry, 283, 20045-20052.
76. Luo, X., Xiao, J., Lin, H., Li, B., Lu, Y., Yang, B., et al. (2007). Transcriptional activation by stimulating protein 1 and posttranscriptional repression by muscle-specific microRNAs of IKs-encoding genes and potential implications in regional heterogeneity of their expressions. Journal of Cellular Physiology, 212, 358-367.
77. Lytle, J. R., Yario, T. A., & Steitz, J. A. (2007). Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. Proceedings of the National Academy of Sciences of the United States of America, 104, 9667-9672.
78. Mandel, E. M., Callis, T. E., Wang, D. Z., & Conlon, F. L. (2005). Transcriptional mechanisms of congenital heart disease. Drug Discovery Today, 2, 33-38.
79. Marber, M. S., Latchman, D. S., Walker, J. M., & Yellon, D. M. (1993). Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation, 88, 1264-1272.
80. Martinez, J., Patkaniowska, A., Urlaub, H., Luhrmann, R., & Tuschl, T. (2002). Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell, 110, 563-574.
81. Mathonnet, G., Fabian, M. R., Svitkin, Y. V., Parsyan, A., Huck, L., Murata, T., et al. (2007). MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science, 317, 1764-1767.
82. Matkovich, S. J., Van Booven, D. J., Youker, K.A., Torre-Amione, G., Diwan, A., Eschenbacher, W. H., et al. (2009). Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation, 119, 1263-1271.
83. Meng, F., Henson, R., Wehbe-Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133, 647-658.
84. Menghini, R., Casagrande, V., Cardellini, M., Martelli, E., Terrinoni, A., Amati, F., et al. (2009). MicroRNA-217 modulates endothelial cell senescence via silent information regulator 1. Circulation, 120, 1524-1532.
85. Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., et al. (2008). Circulating micro- RNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America, 105, 10513-10518.
86. Naga Prasad, S. V., Duan, Z. H., Gupta, M. K., Surampudi, V. S., Volinia, S., Calin, G. A., et al. (2009). Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. Journal of Biological Chemistry, 284, 27487-27499.
87. Ng, E. K., Chong, W. W., Jin, H., Lam, E. K., Shin, V. Y., Yu, J., et al. (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening. Gut, 58, 1375-1381.
88. Petersen, C. P., Bordeleau, M. E., Pelletier, J., & Sharp, P. A. (2006). Short RNAs repress translation after initiation in mammalian cells. Molecular Cell, 21, 533-542.
89. Pillai, R. S., Bhattacharyya, S. N., Artus, C.G., Zoller, T., Cougot, N., Basyuk, E., et al. (2005). Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science, 309, 1573-1576.
90. Place, R. F., Li, L. C., Pookot, D., Noonan, E. J., & Dahiya, R. (2008). MicroRNA-373 induces expression of genes with complementary promoter sequences. Proceedings of the National Academy of Sciences of the United States of America, 105, 1608-1613.
91. Rane, S., He, M., Sayed, D., Vashistha, H., Malhotra, A., Sadoshima, J., et al. (2009). Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circulation Research, 104, 879-886.
92. Ransom, J., & Srivastava, D. (2007). The genetics of cardiac birth defects. Seminars in Cell & Developmental Biology, 18, 132-139.
93. Rao, P. K., Kumar, R. M., Farkhondeh, M., Baskerville, S., & Lodish, H. F. (2006). Myogenic factors that regulate expression of muscle-specific microRNAs. Proceedings of the National Academy of Sciences of the United States of America, 103, 8721-8726.
94. Rao, P. K., Toyama, Y., Chiang, H. R., Gupta, S., Bauer, M., Medvid, R., et al. (2009). Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circulation Research, 105, 585-594.
95. Ren, X. P., Wu, J., Wang, X., Sartor, M. A., Qian, J., Jones, K., et al. (2009). MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation, 119, 2357-2366.
96. Roy, S., Khanna, S., Hussain, S. R., Biswas, S., Azad, A., Rink, C., et al. (2009). MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease- 2 via phosphatase and tensin homologue. Cardiovascular Research, 82, 21-29.
97. Sayed, D., Hong, C., Chen, I. Y., Lypowy, J., & Abdellatif, M. (2007). MicroRNAs play an essential role in the development of cardiac hypertrophy. Circulation Research, 100, 416-424.
98. Sayed, D., Rane, S., Lypowy, J., He, M., Chen, I. Y., Vashistha, H., et al. (2008). MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Molecular Biology of the Cell, 19, 3272- 3282.
99. Scheinowitz, M., Abramov, D., & Eldar, M. (1997). The role of insulin-like and basic fibroblast growth factors on ischemic and infarcted myocardium: A mini review. International Journal of Cardiology, 59, 1-5.
100. Schipper, M. E., van Kuik, J., de Jonge, N., Dullens, H. F., & de Weger, R. A. (2008). Changes in regulatory microRNA expression in myocardium of heart failure patients on left ventricular assist device support. Journal of Heart and Lung Transplantation, 27, 1282-1285.
101. Shan, H., Li, X., Pan, Z., Zhang, L., Cai, B., Zhang, Y., et al. (2009). Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1. British Journal of Pharmacology, 158, 1227-1235.
102. Shan, Z. X., Lin, Q. X., Fu, Y. H., Deng, C. Y., Zhou, Z. L., Zhu, J. N., et al. (2009). Upregulated expression of miR-1/miR- 206 in a rat model of myocardial infarction. Biochemical and Biophysical Research Communications, 381, 597-601.
103. Shilo, S., Roy, S., Khanna, S., & Sen, C. K. (2008). Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 471-477.
104. Silvestri, P., Rigattieri, S., &Loschiavo, P. (2008).Does the effect of microRNAs in vascular neointimal formation depend on cell cycle phase? Circulation Research, 102, e101. author reply e102.
105. Sokol, N. S., & Ambros, V. (2005). Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes and Development, 19, 2343-2354.
106. Subramanian, S., Lui, W. O., Lee, C.H., Espinosa, I., Nielsen, T. O., Heinrich, M. C., et al. (2008). MicroRNA expression signature of human sarcomas. Oncogene, 27, 2015-2026.
107. Suckau, L., Fechner, H., Chemaly, E., Krohn, S., Hadri, L., Kockskamper, J., et al. (2009). Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy. Circulation, 119, 1241-1252.
108. Syed, I. S., Sanborn, T. A., & Rosengart, T. K. (2004). Therapeutic angiogenesis: A biologic bypass. Cardiology, 101, 131-143.
109. Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., et al. (1999). Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Medicine, 5, 434-438. (Pubitemid 29180584)
110. Takaya, T., Ono, K., Kawamura, T., Takanabe, R., Kaichi, S., Morimoto, T., et al. (2009). MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells. Circolo J, 73, 1492-1497.
111. Tang, Y., Zheng, J., Sun, Y., Wu, Z., Liu, Z., & Huang, G. (2009). MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int Heart J, 50, 377-387.
112. Tatsuguchi, M., Seok, H. Y., Callis, T. E., Thomson, J. M., Chen, J. F., Newman, M., et al. (2007). Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. Journal of Molecular and Cellular Cardiology, 42, 1137-1141.
113. Taulli, R., Bersani, F., Foglizzo, V., Linari, A., Vigna, E., Ladanyi, M., et al. (2009). The muscle-specific microRNA miR- 206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. Journal of Clinical Investigation, 119, 2366-2378.
114. Thum, T., Catalucci, D., & Bauersachs, J. (2008). MicroRNAs: Novel regulators in cardiac development and disease. Cardiovascular Research, 79, 562-570.
115. Thum, T., Galuppo, P., Wolf, C., Fiedler, J., Kneitz, S., van Laake, L. W., et al. (2007). MicroRNAs in the human heart: A clue to fetal gene reprogramming in heart failure. Circulation, 116, 258-267.
116. Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., et al. (2008). MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature, 456, 980-984.
117. Urbich, C., Kuehbacher, A., & Dimmeler, S. (2008). Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovascular Research, 79, 581-588.
118. Valastyan, S., Reinhardt, F., Benaich, N., Calogrias, D., Szasz, A. M., Wang, Z. C., et al. (2009). A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell, 137, 1032-1046.
119. van Rooij, E., Quiat, D., Johnson, B. A., Sutherland, L. B., Qi, X., Richardson, J. A., et al. (2009).A family ofmicroRNAs encoded by myosin genes governs myosin expression and muscle performance. Developments in Cell, 17, 662-673.
120. van Rooij, E., Sutherland, L. B., Liu, N., Williams, A. H., McAnally, J., Gerard, R. D., et al. (2006). A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proceedings of the National Academy of Sciences of the United States of America, 103, 18255-18260.
121. van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J.A., Hill, J., & Olson, E. N. (2007). Control of stress-dependent cardiac growth and gene expression by a microRNA. Science, 316, 575-579.
122. van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., et al. (2008). Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proceedings of the National Academy of Sciences of the United States of America, 105, 13027-13032.
123. van Solingen, C., Seghers, L., Bijkerk, R., Duijs, J. M., Roeten, M. K., van Oeveren-Rietdijk, A. M., et al. (2009). Antagomirmediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. Journal of Cellular and Molecular Medicine, 13, 1577-1585.
124. Vasilescu, C., Rossi, S., Shimizu, M., Tudor, S., Veronese, A., Ferracin, M., et al. (2009). MicroRNA fingerprints identify miR- 150 as a plasma prognostic marker in patients with sepsis. PLoS ONE, 4, e7405.
125. Vasudevan, S., Tong, Y., & Steitz, J. A. (2007). Switching from repression to activation: MicroRNAs can up-regulate translation. Science, 318, 1931-1934.
126. Wang, H., Garzon, R., Sun, H., Ladner, K. J., Singh, R., Dahlman, J., et al. (2008). NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell, 14, 369-381.
127. Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., et al. (2008). The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Developments in Cell, 15, 261-271.
128. Wienholds, E., Koudijs, M. J., van Eeden, F. J., Cuppen, E., & Plasterk, R. H. (2003). The microRNA-producing enzyme Dicer1 is essential for zebrafish development. Nature Genetics, 35, 217-218.
129. Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., et al. (2007). Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nature Biotechnology, 25, 1149-1157.
130. Xiao, J., Luo, X., Lin, H., Zhang, Y., Lu, Y., Wang, N., et al. (2007). MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. Journal of Biological Chemistry, 282, 12363-12367.
131. Xu, C., Lu, Y., Pan, Z., Chu, W., Luo, X., Lin, H., et al. (2007). The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. Journal of Cell Science, 120, 3045-3052.
132. Yang, B., Lin, H., Xiao, J., Lu, Y., Luo, X., Li, B., et al. (2007). The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nature Medicine, 13, 486-491.
133. Yekta, S., Shih, I. H., & Bartel, D. P. (2004). MicroRNA-directed cleavage of HOXB8 mRNA. Science, 304, 594-596.
134. Yin, C., Salloum, F. N., & Kukreja, R. C. (2009). A novel role of microRNA in late preconditioning: Upregulation of endothelial nitric oxide synthase and heat shock protein 70. Circulation Research, 104, 572-575.
135. Yin, C., Wang, X., & Kukreja, R. C. (2008). Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice. FEBS Letters, 582, 4137-4142.
136. York, M., Scudamore, C., Brady, S., Chen, C., Wilson, S., Curtis, M., et al. (2007). Characterization of troponin responses in isoproterenolinduced cardiac injury in the Hanover Wistar rat. Toxicologic Pathology, 35, 606-617.
137. Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., et al. (2007). Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell, 129, 303-317.
138. Zhao, Y., Samal, E., & Srivastava, D. (2005). Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature, 436, 214-220.